Cullinan Therapeutics, Inc. reports $49.4 million loss for Q3
CGEM Cullinan Therapeutics Inc
$11.23 -4.26%
View chart & analysis → - 1Cullinan Therapeutics, Inc. reported a $49.4 million loss for the third quarter on Tuesday.
- 2Cullinan Therapeutics, Inc. reported a loss of 74 cents per share for the third quarter.
- 3These results exceeded the average estimate of a 79-cent loss per share from 6 analysts surveyed by Zacks Investment Research.
So what's the key point?
Cullinan Therapeutics, Inc. recorded a loss of $49.4 million in the third quarter. However, the loss was smaller than what experts had expected.
Source Associated Press · View original ↗
Today's 5 AI picks, all freeNothing hidden: past picks and how they did against the S&P 500.